NLB Series

Learn about the latest myeloma research. Get a front row seat at the most critical medical meetings. Watch Dr. Brian Durie, IMF Chairman, address issues that are important to the entire myeloma community. IMF TV brings it all to you.

Jun
10
NLB 2016 Case 4,5,6 Relapsed Myeloma, Treatment for Relapsed MM, Drugs in Development
Case Studies #4, #5, #6: Relapsed Myeloma, Treatment for Relapsed Myeloma, Drugs in Development Tiffany Richards, RN, MS, ANP-C Beth Faiman, PhD , MSN, APRN-BC, AOCN® Start at page 64
Jun
10
NLB 2016: Case #2, 3 Bone Health, Renal Health, 1+Prior Therapies, Immunotherapy, Clonal Evolution
Case Studies #2 and #3: Newly Diagnosed MM, 1+ Prior Therapies, Bone Health, Renal Health, Relapsed Myeloma, Immunotherapy, Clonal Evolution Donna Catamero ANP-BC, OCN®, CCRC Beth Faiman, PhD , MSN,(...)
Jun
10
NLB 2016: Case Study #1 Newly Diagnosed MM, Diagnostic Criteria, Response, MRD
Case Study #1: Newly Diagnosed Multiple Myeloma, Diagnostic Criteria, Response, Extended Treatment Team, Shared Decision Making, Minimal Residual Disease Joseph D. Tariman, PhD, ANP-BC Beth Faiman,(...)
Jun
05
NLB 2015 Case Study #1 Cont.
Case Studies #1 (Cont.): Newly Diagnosed MM Treatment, Adherence, Transplantation, Clinical Trials Teresa Miceli, RN, BSN, OCN® Beth Faiman, PhD , MSN, APRN-BC, AOCN®
Jun
05
NLB 2015 Case Study #2
Case Studies #2: Relapsed Myeloma, Clonal Evolution, Treatment for Relapsed Myeloma, Drugs in Development Sandra Kurtin, RN, MS, AOCN®, ANP-C Beth Faiman, PhD , MSN, APRN-BC, AOCN®
Jun
04
NLB 2015 Case Study #1
Case Study #1: MGUS, SMM, Clinical Trials, New MM Diagnostic Criteria, Newly Diagnosed MM, Minimal Residual Disease Joseph D. Tariman, PhD, ANP-BC Beth Faiman, PhD , MSN, APRN-BC, AOCN®